The Role of Nitric Oxide (Formerly Endothelium-Derived Relaxing Factor-EDRF) in Vasodilatation and Vasodilator Therapy

Moncada S. , Palmer RM J. , Higgs E.A. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991; 43: 109–141.

Furchgott R.F. , Zawadzki J.V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373–376.

Cherry P.D. , Furchgott R.F. , Zawadzki J.V. , Jothianandan D. Role of endothelial cells in relaxation of isolated arteries by bradykinin. Proc Natl Acad Sci USA 1982; 72: 2106–2110.

Griffith T.M. , Edwards D.H. , Lewis M.J. , Newby A.C. , Henderson A.H. The nature of endothelium-derived vascular relaxant factor. Nature 1984; 308: 645–647.

Rubanyi G.M. , Lorenz R.R. , Vanhoutte P.M. Bioassay of endothelium-derived relaxing factor(s): inactivation by catecholamines. Am J Physiol 1985; 249: H95–H101.

Locks T.M. , Angus J.A. , Campbell J.H. , Campbell G.R. Release of endothelium-derived relaxing factor (EDRF) from endothelial cells in culture. J Cell Physiol 1985; 123: 310–320.

Gryglewski R.J. , Moncada S. , Palmer R.M.J. Bioassay of prostacyclin and endothelium derived relaxing factor (EDRF) from porcine aortic endothelial cells. Br J Pharmacol 1986; 87: 685–694.

Singer H.A. , Peach M.J. Endothelium-dependent relaxation of rabbit aorta. 1: relaxation stimulated by arachidonic acid. J Pharmacol Exp Ther 1983; 226: 790–795.

Forstermann U. , Neufang B. The endothelium-dependent vasodilator effect of acetylcholine: characterization of the endothelial relaxing factor with inhibitors of arachidonic acid metabolism. Eur J Pharmacol 1984; 103: 65–70.

Pinto A. , Abraham N.G. , Mullane K.M. Cytochrome P-450-dependent monoxygenase activity and endothelial-dependent relaxations induced by arachnidonic acid. J Pharmacol Exp Ther 1986; 236: 445–451.

Furchgott R.F. Studies on relaxation of rabbit aorta by sodium nitrite: the basis for the proposal that acid-activatable inhibitory factor from bovine retractor penis is inorganic nitrite and the endothelium-derived relaxing factor is nitric oxide. In: Vanhoutte P.M. , ed. Vasodilatation. Vascular smooth muscle, peptide, autonomic nerves, and endothelium. New York: Raven Press, 1988: 401–414.

Ignarro L.J. , Byrns R.E. , Wood K.S. Biochemical and pharmacological properties of endothelium-derived relaxing factor and its similarity to nitric oxide radical. In: Vanhoutte P.M. , ed. Vasodilatation. Vascular smooth muscle, peptide, autonomic nerves, and endothelium. New York: Raven Press, 1988: 427–435.

Bowman A. , Gillespie J.S. , Martin W. Actions on the cardiovascular system of an inhibitory material extracted from the bovine retractor penis. Br J Pharmacol 1981; 72: 365–372.

Gibson Q.H. , Roughton F.J.W. The kinetics and equilibria of the reactions of nitric oxide with sheep haemoglobin. J Physiol 1957; 136: 507–526.

Gruetter C.A. , Barry B.K. , McNamara D.B. , Gruetter D.Y. , Kadowitz P.J. , Ignarro L.J. Relaxation of bovine coronary artery and activation of coronary arterial guanylate cyclase by nitric oxide, nitroprusside and a carcinogenic nitrosoamine. J Cyclic Nucleotide Res 1979; 5: 211224.

Ignarro L.J. , Buga G.M. , Wood K.S. , Byrns R.E. , Chaudhuri G. Endothelium-derived relaxing factors produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 1987; 84: 9265–9269.

Palmer R.M.J. , Ferrige A.G. , Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327: 524–526.

Downes M.J. , Edwards M.W. , Elsey T.S. , Walters C.L. Determination of a non-volatile nitrosamine by using denitrosation and a chemiluminescence analyser. Analyst 1976; 101: 742748.

Kelm M. , Feelisch M. , Spahr R. Quantitative and kinetic characterisation of nitric oxide and EDRF released from cultured endothelial cells. Biochem Biophys Res Comm 1988; 154: 236–244.

Kelm M. , Schrader J. Nitric oxide release from isolated guinea pig heart. Eur J Pharmacol 1988; 155: 317–321.

Ignarro L.J. , Kadowitz P.J. Pharmacological and physiological role of cyclic GMP in vascular smooth muscle relaxation. Ann Rev Pharmacol 1985; 25: 171–191.

Ignarro L.J. , Lippton H.L. , Edwards J.C. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther 1981; 218: 739–749.

Rapoport R.M. , Murad F. Agonist-induced endothelium-dependent relaxation in rat thoracic aorta may be mediated through cGMP Circulation Res 1983; 52: 352–357.

Holzmann S. Endothelium-induced relaxation by acetylcholine associated with larger rises in cyclic GMP in coronary arterial strips. J Cyclic Nucleotide Res 1982; 8: 409–419.

Moncada S. , Palmer R.M.J. , Higgs E.A. The discovery of nitric oxide as the endogenous nitrovasodilator. Hypertension 1988; 12: 365–372.

Mombouli J-V , Illiano S. , Nagao T. , Scott-Burden T. , Vanhoutte P.M. Potentiation of endothelium-dependent relaxations to bradykinin by angiotensin I converting enzyme inhibitors in canine coronary artery involves both endothelium-derived relaxing and hyperpolarizing factors. Circulation Res 1992; 71: 137–144.

Braun M. , Schror K. Prostaglandin D2 relaxes bovine coronary arteries by endothelium dependent nitric oxide-mediated cGMP formation. Circulation Res 1992; 71: 1305–1313.

Angus J.A. , Locks T.M. Endothelium-derived relaxing factor. Pharmac Ther 1989; 41: 303–352.

Long C.J. , Shikano K. , Berkowitz B.A. Anion exchange resins discriminate between nitric oxide and EDRF. Eur J Pharmacol 1987; 142: 317–318.

Dusting G.J. , Read M.A. , Stewart A.G. Endothelium-derived relaxing factor released from cultured cells: differentiation from nitric oxide. Clin Exp Pharmacol Physiol 1988; 15: 83–92.

Shikano K. , Berkowitz B.A. Endothelium-derived relaxing factor is a selective relaxant of vascular smooth muscle. J Pharmacol Exp Ther 1987; 243: 55–60.

Feelisch M. , Noack E.A. Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclase. Eur J Pharmacol 1987; 139: 19–30.

Feelisch M. , Noack E. Nitric oxide (NO) formation from nitrovasodilators occurs independently of hemoglobin or non-heme iron. Eur J Pharmacol 1987; 142: 465–469.

Ignarro L.J. , Lippton H. , Edwards J.C. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Ext Ther 1981; 218: 739–749.

Myers P.R. , Minor R.L. Jr. , Guerra R. Jr. , Bates J.N. , Harrison D.G. Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide. Nature 1990; 345: 161–163.

Stamler J.S. , Simon D.I. , Osborne J.A. S-Nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds. Proc Natl Acad Sci USA 1992; 89: 444–448.

Ignarro L.J. , Gruetter C.A. Requirements of thiols on activation of coronary arterial guanylate cyclase by glyceryl trinitrate and sodium nitrite — possible involvement of S-nitrosothiols. Biochim Biophys Acta 1980; 631: 221–231.

Feelisch M. , Noack E. , Schroder H. Explanation of the discrepancy between the degree of organic nitrate decomposition, nitrite formation and guanylate cyclase stimulation. Eur Heart J 1988; 9 (suppl): 57–62.

Kukovetz W.R. , Holzmann S. Mechanism of nitrate-induced vasodilation and tolerance. Z Kardiol 1983; 72 (suppl 3): 14–19.

Axelsson K.L. , Karlsson J.O.G. Nitroglycerin tolerance in vitro: effect on cGMP turnover in vascular smooth muscle. Acta Pharmacol Toxicol 1985; 55: 203–210.

Kukovetz W.R. , Holzmann S. Mode of action of nitrates with regards to vasodilation and tolerance. Z Kardiol 1986; 75 (suppl): 8–11.

Bult H. , Duyssens N. , DeMeyer G.R.Y. , Jordaens F.H. , Herman A.G. Effects of chronic treatment with a source of exogenous nitric oxide on the release of endothelium-derived relaxing factor by aortae from normal and hypercholesterolaemic rabbits. In: Moncada S. , Higgs E.A. , eds. Nitric oxide from L-arginine: a bioregulatory system. Amsterdam: Excerpta Medica1989: 101–106.

Greenberg S.S. , Wilcox D.E. , Rubanyi G.M. Endothelium-derived relaxing factor released from canine femoral artery cannot be identified as free nitric oxide by electron paramagnetic resonance spectroscopy. Circ Res 1990; 67: 1446–1452.

Vedernikov Y.P. , Mordvincev P.I. , Malenkova I.V. , Vanin A.F. Endothelium-derived relaxing factor is not identical to nitric oxide. In: Moncada S. , Higgs E.A. , eds. Nitric oxide from Larginine: a bioregulatory system. Amsterdam: Excerpta Medica, 1989: 373–377.

Palmer R.M.J. , Ashton D.S. , Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988; 333: 664–666.

Schmidt HHHW , Nau H. , Wittfoht W. Arginine is a physiological precursor of endothelium-derived nitric oxide. Eur J Pharmacol 1988; 154: 213–316.

Sakuma I. , Stuehr D.J. , Gross S.S. , Nathan C. , Levi R. Identification of arginine as a precursor of endothelium-derived relaxing factor. Proc Natl Acad Sci USA 1988; 85: 8664–8667.

Pollock J.S. , Forstermann U. , Mitchell J.A. Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells. Proc Natl Acad Sci USA 1991; 88: 10480–10484.

Salvemini D. , Korbut R. , Anggard E. , Vane J. Immediate release of a nitric-like factor from bovine aorta endothelial cells by Escherichia coli lipopolysaccharide. Proc Natl Acad Sci USA 1990; 87: 2593–2597.

Bredt D.S. , Snyder S.H. Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Natl Acad Sci USA 1990; 87: 682–685.

Bredt D.S. , Snyder S.H. Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc Natl Acad Sci USA 1989; 86: 9030–9033.

Bredt D.S. , Snyder S.H. Nitric oxide, a novel neuronal messenger. Neuron 1992; 8: 3–11.

Johns R.A. EDRF/nitric oxide. The endogenous vasodilator and a new cellular messenger. Anesthesiology 1991; 75: 927–931.

Stuehr D.J. , Cho H.J. , Kwon N.S. , Weise M.F. , Nathan C.F. Purification and characterisation of the cytokine-induced macrophage nitric oxide synthase: an FAD- and FMN-containing flavoprotein. Proc Natl Acad Sci USA 1991; 88: 7773–7777.

Yui Y. , Hattori R. , Kosuga K. Calmodulin-dependent nitric oxide synthase from rat polymorphonuclear neutrophils. J Biol Chem 1991; 266: 3369–3371.

Radomski M.V. , Palmer R.M.J. , Moncada S. Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc Natl Acad Sci USA 1990; 87: 10043–10047.

Bredt D.S. , Hwang P.M. , Glatt C.E. , Lowenstein C. , Reed R.R. , Snyder S. Cloned and expressed nitric oxide synthase structurally resembles cytechrome P-450 reductase. nature 1991; 251: 714–718.

Janssens S.P. , Shimouchi A. , Quertermous T. , Bloch D.B. , Bloch K.D. Cloning and expression of a cDNA encoding human endothelium-derived relaxing factor/nitric oxide synthase. J Biol Chem 1992; 267: 14519–14522.

Klimaschewski L. , Kummer W. , Mayer B. Nitric oxide synthase in cardiac nerve fibers and neurons of rat and guinea pig heart. Circulation Res 1992; 71: 1533–1537.

Amezcua J.L. , Palmer R.M.J. , de Souza B.M. , Moncada S. Nitric oxide synthesized from Larginine regulates vascular tone in the coronary circulation of the rabbit. Br J Pharmacol 1989; 97: 1119–1124.

Rees D.D. , Palmer R.M.J. , Hodson H.F. , Moncada S. A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation. Br J Pharmacol 1989; 96: 418–424.

Levi R. , Gross S.S. , Lamparter B. Evidence that L-arginine is the biosynthetic precursor of vascular and cardiac nitric oxide. In: Moncada S. , Higgs E.A. , eds. Nitric oxide from Larginine: a bioregulatory system. Amsterdam: Excerpta Medica 1989: 35–45.

Rees D.D. , Palmer R.M.J. , Moncada S. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci USA 1989; 86: 3375–3378.

Gardiner S.M. , Compton A.M. , Bennett T. , Palmer R.M.J. , Moncada S. Regional haemodynamic effects of inhibiting endothelial cell production of nitric oxide with NG-monomethyl-Larginine in conscious rats. In: Moncada S. , Higgs E.A. , eds. Nitric oxide from L-arginine: a bioregulatory system. Amsterdam: Excerpta Medica 1989: 81–88.

Gardiner S.M. , Compton A.M. , Bennett T. , Palmer R.M.J. , Moncada S. Persistent haemodynamic changes following prolonged infusions of NG-monomethyl-L-arginine (L-NMMA) in conscious rats. In: Moncada S. , Higgs E.A. , eds. Nitric oxide from L-arginine: a bioregulatory system. Amsterdam: Excerpta Medica 1989: 489–491.

Chu A. , Chambers D.E. , Lin C-C Effects of inhibition of nitric oxide formation on basal vasomotion and endothelium-dependent responses of the coronary arteries in awake dogs. J Clin Invest 1991; 87: 1964–1968.

Yang Z. , Richard V. , Luscher T.F. Endothelium-derived nitric oxide in human arteries and veins. In: Moncada S. , Higgs E.A. , eds. Nitric oxide from L-arginine: a bioregulatory system. Amsterdam: Excerpta Medica 1989: 89–93.

Vallance P. , Collier J. , Moncada S. Nitric oxide synthesised from L-arginine mediates endothelium dependent dilatation in human veins in vivo. Cardiovas Res 1989; 23: 1053–1057.

Vallance P. , Collier J. , Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 1989; 2: 997–1000.

Collier J.G. , Lorge R.E. , Robinson B.F. Comparison of effects of tolmesoxide (RX1107), diazoxide, hydrallazine, prazosin, glyceryl trinitrate and sodium nitroprusside on forearm arteries and dorsal hand veins of man. Br J Clin Pharmacol 1978; 5: 35–44.

Rees D.D. , Palmer R.M.J. , Moncada S. Nitric oxide and the microcirculation. In: Moncada S. , Higgs E.A. eds., Nitric oxide from L-arginine: a bioregulatory system. Amsterdam: Excerpta Medica 1989: 427–437.

Persson M.G. , Gustafsson L.E. , Wiklund N.P. , Hedqvist P. , Moncada S. Endogenous nitric oxide as a modulator of rabbit skeletal muscle microcirculation in vivo. Br J Pharmacol 1990; 100: 463–466.

Seidal C.L. , LaRochelle J. Venous and arterial endothelia: different dilator abilities in dog vessels. Circ Res 1987; 60: 626–630.

Hull S.S. Jr. , Kaiser L. , Jaffe M.D. , Sparks H.V. Jr. Endothelium-dependent flow-induced dilation of canine femoral and saphenous arteries. Blood Vessels 1986; 23: 183–198.

Rubanyi G.M. , Romero J.C. , Vanhoutte P.M. Flow-induced release of endothelium-derived relaxing factor. Am J Physiol 1986; 250: H1145–H1149.

Drexler H. , Zeiher A.M. , Wollschlager H. Flow-dependent coronary artery dilatation in humans. Circulation 1989; 80: 466–474.

Park K.H. , Rubin L.E. , Grass S.S. , Levi R. Nitric oxide is a mediator of hypoxic coronary vasodilatation. Circulation Res 1992; 71: 992–1001.

Brum J.M. , Sufan Q. , Lane G. , Bove A.A. increased vasoconstrictor activity of proximal coronary arteries with endothelial damage in intact dogs. Circulation 1984; 6: 1066–1073.

Joly G.A. , Schini V.B. , Vanhoutte P.M. Balloon injury and interleukin-1b induce nitric oxide synthase activity in rat carotid arteries. Circulation Res 1992; 71: 331–338.

Jayakady L. , Senaratne M. , Thomson A. , Kappagoda T. Endothelium-dependent relaxation in experimental atherosclerosis in the rabbit. Circ Res 1987; 60: 251–264.

Forstermann U. , Mugge A. , Alheid U. , Haverich A. , Frolich J.C. Selective attenuation of endothelium-mediated vasodilation in atherosclerotic human coronary arteries. Circ Res 1988; 62: 185–190.

Chester A.H. , O'Neil G.S. , Moncada S. , Tadjkarimi S. , Yacoub M.H. Low basal and stimulated release of nitric oxide in atherosclerotic epicardial coronary arteries. Lancet 1990; 336: 897–900.

Luscher T.F. , Raij L. , Vanhoutte P.M. Endothelium-dependent vascular responses in normotensive and hypertensive Dahl rats. Hypertension 1987; 9: 157–163.

Panza J.A. , Quyyumi A.A. , Brush J.E. , Epstein S.E. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. New Engl J Med 1990; 323: 22–27.

Linder L. , Kiowski W. , Buhler F.R. , Luscher T.F. Indirect evidence for the release of endothelium-derived relaxing factor in human forearm circulation in vivo. Blunted response in essential hypertension. Circulation 1990; 81: 1762–1767.

Palmer R.M.J. , Bridge L. , Foxwell N.A. , Moncada S. The role of nitric oxide in endothelial cell damage and its inhbition by glucocorticoids. Br J Pharmacol 1992; 105: 11–12.

Jolou-Schaeffer G. , Gray G.A. , Fleming I. Loss of vascular responsiveness induced involves L-arginine pathway. Am J Physiol 1990; 259: H1038–H1043.

Kilbourn R.G. , Gross S.S. , Jubran A. NG-Methyl-L-arginine inhibits tumour necrosis factor-induced hypotension. Implications for the involvement of nitric oxide. Proc Natl Sci USA 1990; 87: 3629–3632.

Nava E. , Palmer R.M.J. , Moncada S. Inhibition of nitric oxide synthesis in septic shock: how much is beneficial? Lancet 1991; 338: 1555–1557.

Wright C.E. , Rees D.D. , Moncada S. Protective and pathological roles of nitric oxide in endotoxin shock. Cardiovasc Res 1992; 26: 48–57.

Petras A. , Bennett D. , Vallance P. Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet 1991; 338: 1557–1558.

Anon. Wellcome's nitric oxide blocker set for sepsis hypotension trial. Pharmaceutical J 1992; July 27: 834.

Vallance P. , Moncada S. Hyperdynamic circulation in cirrhosis: a role for nitric oxide? Lancet 1991; 337: 776–778.

Martin W. , Villani G.M. , Jothianandan D. , Furchgott R.F. Selective blockade of endotheliumdependent and glyceryl trinitrate-induced relaxation of hemoglobin and by methylene blue in the rabbit aorta. J Pharmacol Exp Ther 1985; 232: 708–716.

Midgley S. , Grant I.S. , Haynes W.G. , Webb D.J. Nitric oxide in liver failure (Letter). Lancet 1991; 338: 1590.

Vallance P. , Leone A. , Calver A. , Collier J. , Moncada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 1992; 339: 572–575.

Stamler J.S. , Singel D.J. , Loscalzo J. Biochemistry of nitric oxide and its redox-activated forms. Science 1992; 258: 1898–1902.

Wagner H. Absorption von NO and NO₂ in MIK- and MIK-Konzentration bei inhalation. Staub Reinhalt Luft 1970; 30: 380–381.

Oda H. , Kusumato S. , Nakajima T. Nitrosyl-hemoglobin formation in the blood of animals exposed to nitric oxide. Arch Environ Health 1975; 30: 453–456.

Yoshida K. , Kasana K. , Kitabatake M. , Okuda M. , Imai M. Metabolic fate of nitric oxide. Int Arch Occup Environ Health 1980; 46: 71–77.

Norman V. , Keith C.H. Nitrogen oxides in tobacco smoke. Nature 1965; 205: 915–916.

Clutton-Brock J. Two cases of poisoning by contamination of nitrous oxide with higher oxides of nitrogen during anaesthesia. Br J Anaesth 1967; 39: 388–392.

Greenbaum R. , Bay J. , Hargreaves M.D. Effects of higher oxides of nitrogen on the anaesthetised dog. Br J Anaesth 1967; 39: 393–404.

Shiel FO'M. Morbid anatomical changes in the lungs of dogs after inhalation of higher oxides of nitrogen during anaesthesia. Br J Anaesth 1967; 39: 413–423.

Toothill C. The chemistry of the in vivo reaction between haemoglobin and various oxides of nitrogen. Br J Anaesth 1967; 39: 405–412.

Meyer M. , Piper J. Nitric oxide (NO), a new test gas for study of alveolar-capillary diffusion. Eur Respir J 1989; 2: 494–496.

Foubert L. , Fleming B. , Latimer R. Safety guidelines for use of nitric oxide (Letter). Lancet 1992; 339: 1615–1616.

Law-Koune J.D. , Moutafis M. , Fischler M. Production of N02 during nitric oxide (NO) inhalation. Intens Care Med 1992; 18: S67.

Worksafe Australia, Exposure standards for atmospheric contaminants in the occupational environment, 2nd ed. Commonwealth Government of Australia, Sydney 1991: 100–101.

Thomas H.V. , Mueller P.K. , Lyman R.L. Lipid peroxidation of lung lipids in rats exposed to nitrogen dioxide. Science 1968; 159: 532–534.

Rasmussen T.R. , Kjaergaard S.K. , Tarp U. , Pedersen O.F. Delayed effects of N02 exposure on alveolar permeability and glutathione peroxidase in healthy humans. Am Rev Respir Dis 1992; 146: 654–659.

von Nieding G. , Wagner H.M. Vergleich der wirkung von stickstoffdioxid und stickstoffmonoxid auf die Lungenfunktion des menschen. Staub-Reinhalt Luft 1975; 35: 175–178.

von Nieding G. , Wagner H.M. , Kreheler H. Investigation of the acute effects of nitrogen monoxide on lung function in man. In: Proceedings of the 3rd International Clean Air Congress, Dusseldorf, October 8-12. Dusseldorf: VDI-Verlag, 1973: A14–A16.

Man S.F.P. , Williams D.J. , Amy R.A. , Man G.C.W. , Lien D.C. Sequential changes in canine pulmonary epithelial and endothelial cell functions after nitrogen diozide. Am Rev Respir Dis 1990; 142: 199–205.

Stavert D.M. , Lehnert B.E. Nitrogen oxide and nitrogen dioxide as inducers of acute pulmonary injury when inhaled at relatively high concentrations for brief periods. Inhal Toxicol 1990; 2: 53–67.

Kawakami M. , Yasui S. , Yamawaki I. , Katayama M. , Nagai A. , Takizawa T. Structural changes in airways of rats exposed to nitrogen dioxide intermittently for seven days. Am Rev Respir Dis 1989; 140: 1754–1762.

Mohsenin V. , John B. Effect of N02 exposure on bronchial reactivity of normal and asthmatic subjects. Am Rev Respir Dis 1986; 133: A215.

Bauer M.A. , Utell M.J. , Morrow P.E. , Speers D.M. , Gibb F.R. 0.30 ppm nitrogen dioxide inhalation potentiates exercise-induced bronchospasm in asthmatics. Am Rev Respir Dis 1984; 129: A151.

Bauer M.A. , Utell M.J. , Smeglin A.M. , Speers D.M. , Gibb F.R. , Morrow P.E. Effects of low-level nitrogen dioxide on lung function in exercising subjects with chronic obstructive pulmonary disease (COPD). Am Rev Respir Dis 1986; 133: A215.

Leaf C.D. , Wishnok J.S. , Tannenbaum S.R. Nitric oxide: the dark side. In: Moncada S. , Higgs E.A. , eds. Nitric oxide from L-arginine: a bioregulatory system. Amsterdam, Excerpta Medica 1990: 291–299.

Ohshima H. , Bartsch H. Quantitative estimation of endogenous nitrosation in humans by monitoring N-nitrosoproline excretion in the urine. Cancer Res 1981; 41: 3658–3666.

Leaf C.D. , Wishnok J.S. , Tannenbaum S.R. L-arginine is a precursor for nitrate biosynthesis in humans. Biochem Biophys Res Commun 1989; 163: 1032–1037.

Frostell C. , Fratacci M-D , Wain J.C. , Jones R. , Zapol W.M. Inhaled nitric oxide: a selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 1991; 31: 2038–2047.

Hugod C. Effects of exposure to 43 ppm nitric oxide and 3.6 ppm nitrogen dioxide on rabbit lung. Int Arch Occup Environ Health 1979; 42: 159–167.

Davidson D. , Eldemerdash A. Endothelium-derived relaxing factor: presence in pulmonary and systemic arteries of the newborn guinea pig. Pediatr Res 1990; 27: 128–132.

Abman S.H. , Chatfield B.A. , Hall S.L. , McMurtry I.F. Role of endothelium-derived relaxing factor during transition of pulmonary circulation at birth. Am J Physiol 1990; 259: H1921–1927.

Fireman J.R. , Heymann M.A. , Soifer S.J. Nw-nitro-L-arginine attenuates endothelium dependent pulmonary vasodilation in lambs. Am J Physiol 1991; 260: 1299–1306.

Adnot S. , Raffestin B. , Eddahibi S. , Braquet P. , Chabrier P-E. Loss of endothelium-dependent relaxant activity in the pulmonary circulation of rats exposed to chronic hypoxia. J Clin Invest 1991; 87: 155–162.

Shaul P.W. , Farrar M.A. , Zellers T.M. Oxygen modulates endothelium-derived relaxing factor production in fetal pulmonary arteries. Am J Physiol 1992; 262: H355–364.

Maruyama J. , Maruyama K. , Muneyuki M. Endothelium-dependent and independent relaxation in pulmonary arteries of rats during recovery from chronc hypoxia. Am Rev Respir Dis 1992; 45: A206.

Eddahibi S. , Carville C. , Raffastin B. , Adnot S. In vivo administration of L-arginine restores endothelium dependent relaxant activity in the pulmonary circulation of chronically hypoxic rats. Am Rev Respir Dis 1992; 145: A208.

Oka M. , Hasunuma K. , Rodman D. , McMurtry I.F. Inhibition of endothelium-derived relaxing factor causes vasoconstriction in hypertensive rat lungs. Am Rev Respir Dis 1992; 145: A208.

Fratacci M-D , Frostell C.G. , Chen T-Y Inhaled nitric oxide: a selective pulmonary vasodilator of heparin-protamine in sheep. Anesthesiology 1991; 75: 990–999.

Roberts J.D. , Chen T-Y , Wain J. , Polaner D. , Dupvay P. , Zapol W.M. Nitric oxide gas is a selective pulmonary vasodilator in the newborn lamb during hypoxemia and acidosis. Pediatr Res 1992; 31: 320A.

Channick R.N. , Bradley S.P. , Newhart J.W. Inhaled nitric oxide reverses hypoxic pulmonary vasoconstriction in dogs. Am Rev Respir Dis 1992; 145: A209.

Roberts J.D. , Polaner D.M. , Lang P. , Zapol W.M. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1992; 340: 818–819.

Kinsella J.P. , Neish S.R. , Shaffer E. , Abman S.H. Low-dose inhalational nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1992; 340: 819–820.

Pepke-Zaba J. , Higenbottam T.W. , Dinh-Xuan A.T. , Stone D. , Wallwork J. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. Lancet 1991; 338: 1173–1174.

Rossaint R. , Falke K.J. , Lopez F. Inhaled nitric oxide for the adult respiratory distress syndrome. NEJM 1993; 328: 399–405.

Slama K. , Rossaint R. , Keitel M. , Lewandowski K. , Steudel W. , Falke K. Effects of inhaled nitric oxide and IV prostacyclin on right ventricular function in patients with severe ARDS. Intens Care Med 1992; 18: S66.

Bigatello L.M. , Hurford W.E. , Kacmarek R.M. , Roberts J.D. Jr. , Zapol W.M. Inhaled nitric oxide is a selective pulmonary vasodilator in septic patients with severe ARDS. Am Rev Respir Dis 1992; 145: A185.

Kacmarek R.M. Inhaled nitric oxide (EDRF) in ARDS. New Zealand Society for Respiratory Care, Annual Scientific Meeting, Auckland, Oct 14, 1992.

Payen D. , Gatecel C. , Guinard N. Inhalation of low dose NO and IV L-arginine in ARDS: effect on pulmonary hemodynamic and gas exchange. Intens Care Med 1992; 18: S66.

Fratacci M.D. , Defouilley C. , Andrivet P. Responses to infusion of acetylcholine and inhalation of nitric oxide in patients with chronic obstructive lung disease and pulmonary hypertension. Am Rev Respir Dis 1992; 145: A722.

Moinard J. , Pillet O. , Castaing Y. , Guenard H. Inhaled nitric oxide: effects on pulmonary circulation and gas exchanges in man. Am Rev Respir Dis 1992; 145: A207.

Dinh-Xuan A.T. , Higenbottam T.W. , Clelland C.A. Impairment of endothelium-dependent pulmonary artery relaxation in chronic obstructive lung disease. New Engl J Med 1991; 324: 1539–47.

Dinh-Xuan A.T. , Higenbottam T.W. , Pepke-Zaba J. , Butt A.Y. , Cremona G. Evidence for dysfunction of the enzyme, nitric oxide synthase, in the mechanisms of impaired pulmonary endothelium-dependent relaxation in chronic hypoxic lung disease. Am Rev Respir Dis 1992; 145: A207.

Robert J.D. Jr. , Lang P. , Bigatello L.M. , Vlahakes G.J. , Zapol W.M. Inhaled nitric oxide in congenital heart disease. Circulation 1993; 87: 447–453.

Tibballs J. Clinical applications of gaseous nitric oxide. Anaesth Intens Care 1993; 6: 866–871.

Vauhoutte P.M. Epithelium-derived relaxing factor(s) and bronchial reactivity. Am Rev Respir Dis 1988; 138: S24–30.

Arnold W.P. , Aldred R. , Murad F. Cigarette smoke activates guanylate cyclase and increases guanosine 3¹-5¹-monophosphate in tissues. Science 1977; 198: 934–936.

Gruetter C.A. , Childres C.E. , Bosserman M.K. , Lemke S.M. , Ball J.G. , Valentovic M.A. Comparison of relaxation induced by glyceryl trinitrate, isosorbide dinitrate and sodium nitroprusside in bovine airways. Am Rev Respir Dis 1989; 139: 1192–1197.

Jamieson D.D. , Taylor K.M. Comparison of the bronchodilator and vasodilator activity of sodium oxide and sodium nitroprusside in the guinea-pig. Clin Exp Pharmacol Physiol 1979; 6: 515–525.

Arnold W.P. , Mittal C.K. , Katsuki S. , Murad F. Nitric oxide activates guanylate cyclase and increases guanosine 3¹: 5¹-cyclic monophosphate levels in various tissue preparations. Proc Natl Acad Sci 1977; 74: 3203–3207.

Dupuy P.M. , Shore S.A. , Drazen J.M. , Frostell C. , Hill W.A. , Zapol W.M. Bronchodilator action of inhaled nitric oxide in guinea pigs. J Clin Invest 1992; 90: 421–428.

Hogman M. , Hedenstrom H. , Frostell C. , Arnberg H. , Hedenstierna G. Is nitric oxide inhalation beneficial to the asthmatic patient? Intens Care Med 1992; 18: S169.

Tibballs J. , Hochmann M. , Carter B. , Osborne A. An appraisal of techniques for administration of gaseous nitric oxide. Anaesth Intens Care 1993; 6: 844–847.

Petros A.J. , Cox P.B. , Bohn D. Simple method for monitoring concentrations of inhaled nitric oxide (letter). Lancet 1992; 340: 1167.